SMA Newborn Screening Kits
About This Opportunity
Award notice from NHS Greater Glasgow and Clyde (United Kingdom) — SMA Newborn Screenin. healthcare. Awarded to Labsystems Diagnostics OY (GBP 238K, Mar 2026).
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in United Kingdom, Europe, this opportunity is open to firms and consortiums.
Published through UK FTS - Find a Tender Service, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
The Scottish Newborn Screening Laboratory has been commissioned to participate in the in-service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement is to screen dried blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).
The Scottish Newborn Screening Laboratory has been commissioned to participate in the in service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement to screen died blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).
Scotland has begun a 2 year evaluation of SMA screening on behalf of the National Screening Committee to gather data to allow a decision to be made about if SMA screening should be included in the UK Newborn Screening Panel. SMA is cause by a deletion of the SMN1 gene, but the severity of the disease depends on another gene called SMN2. SMN2 is present in all babies in various copy numbers, and the lower the copy number the more severe the disease. Additional information: 300 kits required across a 24 month period, with 25 kits to be shipped every 8 weeks, depending on the demand of the service.
Data provenance
This notice is sourced from UK FTS - Find a Tender Service and was originally published on March 19, 2026. Last refreshed today. Reference: 025039-2026. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About NHS Greater Glasgow and Clyde
NHS Greater Glasgow and Clyde has issued 202 procurement notices on BidsFactory, including 28 currently open and 125 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Transport & Logistics. All notices are published for United Kingdom. Notices are distributed via Public Contracts Scotland and UK FTS - Find a Tender Service. Most recent publication: May 1, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit UK FTS - Find a Tender Service to access the full notice, required documents, and submission instructions. Quote reference 025039-2026 when communicating with the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Labsystems Diagnostics OY. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by NHS Greater Glasgow and Clyde in United Kingdom. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Labsystems Diagnostics OY was awarded the contract for £237,847. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in United Kingdom. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.